API reference

Lacosamide

CAS number
175481-36-4
Molecular formula
C13H18N2O3
Molecular weight
250.29 g/mol
Lacosamide — 2D structure
2D structure (PubChem)

About this molecule

Lacosamide is a functionalized amino acid compound specifically synthesized as an anticonvulsive drug to use as add-on therapy for partial-onset seizures with antinociceptive and neuroprotective activities. Lacosamide selectively enhances slow inactivation of voltage-gated sodium channels without affecting fast inactivation, thereby stabilizing hyperexcitabe neuronal membranes. Furthermore, this agent binds to collapsin response mediator protein 2 (CRMP2; DPYSL2), a cytosolic phosphoprotein expressed in most tissues. In the nervous system, CRMP2 acts as a mediator of growth cone collapse as well as modifies axon number, length, and neuronal polarity.

Source: NCI Thesaurus (NCIt), via PubChem.

Identifiers

IUPAC name
(2R)-2-acetamido-N-benzyl-3-methoxypropanamide
InChIKey
VPPJLAIAVCUEMN-GFCCVEGCSA-N
SMILES
CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1
PubChem CID
219078

Also known as

Lacosamide · Erlosamide · Vimpat · Harkoseride · SPM 927 · SPM-927 · (r)-lacosamide 1 · MOTPOLY

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com